With our new BSL-2 housing for the conduct of short- and long-term Influenza studies in ferrets and rodents, Charles River can now provide a full portfolio of products and services for vaccine development, from influenza virus stocks to in vivo vaccine studies.
Announcing Biologics Testing Solutions, our comprehensive portfolio of testing for biologics development and manufacturing. Placing your biologics testing study with Charles River reduces your risk of unexpected results and will make you feel like your sample never left your hands.
Automated, high-precision kinematic movement analysis system is a more sensitive and complete way of detecting motor abilities in animals that model CNS diseases. For the first time, fine motor kinematic analysis in animal models brings a translatable assay for motor testing.
Our new, complimentary IT solution, offered through the Accugenix® customer portal, generates the tracking and trending reports required to ensure the long-term safety of your manufacturing environment, while meeting the demands of compliance.
We provide cost-effective, rapid PK screening with flexible start times and can help you design study protocols to meet your customized needs. Our experts can assess the pharmacokinetic profile of your compounds in a wide range of administration routes and dosing regimens in rodent and nonrodent species.
We are pleased to announce the appointment of Emily Hickey to the position of Corporate Vice President for Discovery Research Services. Emily’s experience and knowledge of the industry adds significant value to Charles River.
We are extremely proud to announce that our Edinburgh site has received a second award for humane care. This award recognizes our introduction of floor housing of rabbits as part of our ongoing commitment to environmental enrichment.
Fundus autofluorescence offers an additional noninvasive way of assessing test article effects on the eye. Ophthlamic examinations allow an examiner to visually assess the eye for test article effects.
Charles River is pleased to announce that our 2014 Research Models and Services catalog is now available electronically.
We have recently received approval to move forward with the expansion of our existing Avian Vaccine Services laboratory manufacturing site to further meet expanding customer demand. The new expanded facility’s ground breaking is imminent.